Ultomiris 300 mg/3 ml, Konzentrat zur Herstellung einer Infusionslösung
7680672780023
CH-67278
Konzentrat
Associated product:
ULTOMIRIS conc perf 300 mg/3ml flac 3 ml
1 / 3
google
Article details
- Package size
- 1
- Selling units
- 1
- Measure
- Durchstechflasche(n)
- Galenic form
- Konzentrat
- Galenic group
- Tinkturen/Desinfektion
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
ravulizumabum
|
300.0 MG | Substance | Wirkstoff (Principe actif) |
|
natrii dihydrogenophosphas monohydricus
|
- | Substance | HNIDK |
|
dinatrii phosphas heptahydricus
|
- | Substance | HNIDK |
|
argininum
|
- | Substance | HNIDK |
|
saccharum
|
- | Substance | HNIDK |
|
polysorbatum 80
|
- | Substance | HNIDK |
|
aqua ad iniectabile
|
- | Substance | HNIDK |
|
natrium
|
4.6 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 4181.20
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/03/2022
Authorization holder
Alexion Pharma GmbH
6340 Baar
Authorization information
- Swissmedic authorization number
- 67278
- Drug name
- Ultomiris, Konzentrat zur Herstellung einer Infusionslösung
- Galenic form
- KOINF
- ATC Code
- L04AJ02
- Authorization status
- Z
- Dispensing category
- A
- First authorization
- 20/01/2020
- Authorization expiration date
- 31/12/9999
- IT Number
- 07.15.0.
- Domain
- Human medicine
Package details
- Description (FR)
- ULTOMIRIS conc perf 300 mg/3ml flac 3 ml
- Description (DE)
- ULTOMIRIS Inf Konz 300 mg/3ml Durchstf 3 ml
- Market launch
- 16/09/2021
- Narcotic (BTM)
- No